1-1 of 1
Peter Kang, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Gemtuzumab Ozogamycin (GO) and Cytarabine (ARA-C) in Patients with High Risk MDS and AML..

Peter Kang, MD, Karen Seiter, MD, Delong Liu, MD, PhD, Muhammad Arshad, MD, Anila Qureshi, MD, John Nelson, MD, Tauseef Ahmed, MD
Journal: Blood
Blood (2004) 104 (11): 4723.
https://doi.org/10.1182/blood.V104.11.4723.4723
Published: 2004